For individuals
Blood test and app
Blog
FAQ
Buy
Sign in
For business
Nightingale for business
Health initiatives
For investors
Investor pages
Nightingale as an investment
Financial information
Share and shareholders
Governance
Investor relations
Releases
Reports and presentations
IPO
Suomeksi
For research
Blood Biomarker Analysis
Biomarkers
Publications
About us
Company
Technology
News
Careers
Contact
For individuals
For business
For investors
About us
Investor contacts
Investors
Home
Nightingale as an investment
Key strengths
CEO's greetings
Operational environment
Strategy
Dividends policy
Financial information
Key figures
Share and shareholders
Share information
Share monitor
Shareholders
Authorisations
Governance
Governance principles
General Meeting
Annual General Meeting 2021
Board of Directors
Management Team
Remuneration
Risk management
Insider management
Managers' transactions
Auditor
Certified Adviser
Articles of Association
Code of Conduct
Investor relations
Investor calendar
Investor contacts
Disclosure policy
Releases
Company releases
Press releases
Managers' transactions
Reports and presentations
Reports and presentations
IPO
IPO 2021
Investors
Investor contacts
IR contacts
ir@nightingalehealth.com
Nightingale Health Plc
Mannerheimintie 164a, 00300 Helsinki, Finland
For individuals
Blood test and app
Blog
FAQ
Buy
Sign in
For business
Nightingale for business
Health initiatives
For investors
Investor pages
Nightingale as an investment
Financial information
Share and shareholders
Governance
Investor relations
Releases
Reports and presentations
IPO
Suomeksi
For research
Blood Biomarker Analysis
Biomarkers
Publications
About us
Company
Technology
News
Careers
Contact
Get our newsletter
Interested in getting the latest news about Nightingale? Subscribe to our newsletter.
→
Nightingale Health Oyj
Mannerheimintie 164a, 00300 Helsinki, Finland
Contact →
© 2020 Nightingale Health
Terms and policies